Braegen
Latest round
- Series A
Last raised
- Nov 2024
Total raised
- Undisclosed
Investors
- 4
About Braegen
Founded in 2015 and based in Shenzhen, China, Braegen specializes in developing drugs for central nervous system disorders. The company has R&D management teams and technology transformation centers in Shanghai and Shenzhen respectively. Jie Zhang, the company's co-founder and CEO, was formerly executive vice president of MicroPort Medical. Braegen Pharmaceutical focuses on developing innovative drugs for central nervous system (CNS) diseases. Their flagship product, BrAD-R13, is a first-in-class small molecule TrkB receptor agonist aimed at treating mild to moderate Alzheimer's disease. Additionally, the company is developing a PET imaging agent for early Parkinson's disease diagnosis, targeting markets in North America and Asia. The company’s revenue is generated by providing small molecule oral drugs and radiopharmaceuticals.
Who invested in Braegen
4 investors across 2 rounds
See all investors in Braegen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Braegen
Who invested in Braegen?
Braegen has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Braegen raised?
Braegen has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Braegen last raise money?
Braegen's most recent round on record is a Series A, in Nov 2024.
What does Braegen do?
Founded in 2015 and based in Shenzhen, China, Braegen specializes in developing drugs for central nervous system disorders.
Where is Braegen headquartered?
Braegen is headquartered in Shenzhen, China.
Which VCs invest in companies like Braegen?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Braegen's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Braegen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.